IV and tablet placebo identifical to the active products will be produced by: clinical trials

Aciclovir for HSV-2 MENingitis: A double-blinded randomised controlled trial (AMEN)

This study is looking at whether a medicine called aciclovir can help people with meningitis caused by the herpes simplex virus (HSV-2). It's a follow-up study (Phase IV) to see if the treatment works well in everyday medical care and to learn more about its effects.